OA09702A - The use of gaba-B selective agonists as antitussive agents. - Google Patents

The use of gaba-B selective agonists as antitussive agents.

Info

Publication number
OA09702A
OA09702A OA60231A OA60231A OA09702A OA 09702 A OA09702 A OA 09702A OA 60231 A OA60231 A OA 60231A OA 60231 A OA60231 A OA 60231A OA 09702 A OA09702 A OA 09702A
Authority
OA
OAPI
Prior art keywords
gaba
selective agonists
antitussive agents
mammal
antitussive
Prior art date
Application number
OA60231A
Inventor
William Kreutner
Gail F Seelig
Paul P Trotta
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of OA09702A publication Critical patent/OA09702A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

A method for treating cough in a mammal comprising administering to said mammal an anti-tussive effective amount of a GABA-B selective agonist such as <IMAGE> is described.
OA60231A 1989-12-20 1992-06-19 The use of gaba-B selective agonists as antitussive agents. OA09702A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/454,786 US5006560A (en) 1989-12-20 1989-12-20 Use of GABA-B selective agonists as anti-tussive agents

Publications (1)

Publication Number Publication Date
OA09702A true OA09702A (en) 1993-08-30

Family

ID=23806078

Family Applications (1)

Application Number Title Priority Date Filing Date
OA60231A OA09702A (en) 1989-12-20 1992-06-19 The use of gaba-B selective agonists as antitussive agents.

Country Status (14)

Country Link
US (1) US5006560A (en)
EP (1) EP0506853B1 (en)
JP (1) JPH06102630B2 (en)
KR (1) KR950007208B1 (en)
AT (1) ATE106725T1 (en)
AU (1) AU642969B2 (en)
CA (1) CA2071981C (en)
DE (1) DE69009778T2 (en)
DK (1) DK0506853T3 (en)
ES (1) ES2055587T3 (en)
FI (1) FI922798A0 (en)
HU (1) HU212271B (en)
OA (1) OA09702A (en)
WO (1) WO1991008740A1 (en)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5214054A (en) * 1988-05-18 1993-05-25 Novo Nordisk A/S Azacyclic carboxylic acid derivatives and their preparation and use
US5229404A (en) * 1988-05-18 1993-07-20 Novo Nordisk A/S Azacyclic carboxylic acid derivatives and their preparation and use
US5231106A (en) * 1988-05-18 1993-07-27 Novo Nordisk A/S Azacyclic carboxylic acid derivatives and their preparation and use
DK588189D0 (en) * 1989-11-22 1989-11-22 Novo Nordisk As NEW HETEROCYCLIC CARBOXYLIC ACIDS
US5182266A (en) * 1990-01-31 1993-01-26 Abbott Laboratories Method for treating renal disease
FR2662354B1 (en) * 1990-05-23 1994-10-07 Adir USE OF BACLOFENE FOR OBTAINING MEDICINAL PRODUCTS FOR THE TREATMENT OF ANGINA OF CHEST.
GB9117716D0 (en) * 1991-08-16 1991-10-02 Lynxvale Ltd Gaba derivatives and their therapeutic application
US6194460B1 (en) * 1995-05-31 2001-02-27 Montefiore Medical Center Composition for treating cough induced by angiotensin converting enzyme inhibitors
DE69738396T2 (en) * 1996-05-24 2008-12-04 Smithkline Beecham Corp. USE OF GABA RECORD INHIBITORS AS AGENTS AGAINST HUSTEN
CA2327285C (en) * 1998-05-15 2005-06-14 Warner-Lambert Company Stabilized pharmaceutical preparations of gamma-aminobutyric acid derivatives and process for preparing the same
SE9904508D0 (en) 1999-12-09 1999-12-09 Astra Ab New compounds
US7319095B2 (en) 1999-12-09 2008-01-15 Astrazeneca Ab Use of GABAB receptor agonists
EP2354120A1 (en) 2003-08-20 2011-08-10 XenoPort, Inc. Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof
KR20110097942A (en) * 2003-08-20 2011-08-31 제노포트 인코포레이티드 Acyloxyalkyl carbamate prodrugs, synthesis and methods of use
US7566738B2 (en) * 2004-11-03 2009-07-28 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs of sulfinic acids, methods of synthesis, and use
WO2006050472A2 (en) * 2004-11-03 2006-05-11 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs of 3-aminopropylphosphonous and -phosphinic acids
US20060160777A1 (en) * 2004-12-27 2006-07-20 Anders Lehmann New use of GABAbeta receptor agonists
US7585996B2 (en) * 2006-09-15 2009-09-08 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs, methods of synthesis and use
CA2674610C (en) * 2007-01-11 2013-06-18 Xenoport, Inc. Sustained release oral dosage forms of a prodrug of r-baclofen and methods of treatment
TW200936123A (en) * 2007-11-06 2009-09-01 Xenoport Inc Use of prodrugs of GABAb agonists for treating neuropathic and musculoskeletal pain
ES2601852T3 (en) * 2008-01-25 2017-02-16 Xenoport, Inc. Crystalline form of calcium salts of (3S) -aminomethyl-5-methyl-hexanoic acids and methods of use
EP2250148B1 (en) 2008-01-25 2016-08-17 XenoPort, Inc. Crystalline form of calcium-salts of (3s)-aminomethyl-5-methyl-hexanoic acids and methods of use
WO2009094577A2 (en) 2008-01-25 2009-07-30 Xenoport, Inc. Mesophasic forms of (3s)-aminomethyl-5-methyl-hexanoic acid prodrugs and methods of use
US20100137442A2 (en) * 2008-02-01 2010-06-03 Xenoport, Inc. Sustained Release Particulate Oral Dosage Forms of (R)-Baclofen and Methods of Treatment
EP2309858A4 (en) 2008-07-31 2011-09-14 Dekel Pharmaceuticals Ltd Compositions and methods for treating inflammatory disorders
WO2010017504A1 (en) * 2008-08-07 2010-02-11 Xenoport, Inc. Methods of synthesizing 1-(acyloxy)-alkyl carbamate prodrugs
US7989641B2 (en) 2008-08-07 2011-08-02 Xenoport, Inc. Methods of synthesizing N-hydroxysuccinimidyl carbonates
JP2012519212A (en) * 2009-03-03 2012-08-23 ゼノポート，インコーポレイティド R-baclofen prodrug sustained release oral dosage form
JP2012524065A (en) * 2009-04-17 2012-10-11 ゼノポート，インコーポレーテッド Γ-aminobutyric acid derivatives as GABAB receptor ligands
US8580850B2 (en) 2011-08-11 2013-11-12 Xenoport, Inc. Anhydrous and hemihydrate crystalline forms of an (R)-baclofen prodrug, methods of synthesis and methods of use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH449645A (en) * 1963-07-09 1968-01-15 Ciba Geigy Process for the production of new amino acids

Also Published As

Publication number Publication date
US5006560A (en) 1991-04-09
HU9202077D0 (en) 1992-09-28
FI922798L (en) 1992-06-17
DE69009778D1 (en) 1994-07-14
AU7174591A (en) 1991-07-18
EP0506853A1 (en) 1992-10-07
FI922798A7 (en) 1992-06-17
JPH05504764A (en) 1993-07-22
HUT61194A (en) 1992-12-28
EP0506853B1 (en) 1994-06-08
DK0506853T3 (en) 1994-08-01
ES2055587T3 (en) 1994-08-16
DE69009778T2 (en) 1994-09-22
FI922798A0 (en) 1992-06-17
ATE106725T1 (en) 1994-06-15
WO1991008740A1 (en) 1991-06-27
CA2071981C (en) 2002-06-25
KR920703043A (en) 1992-12-17
JPH06102630B2 (en) 1994-12-14
HU212271B (en) 1996-04-29
KR950007208B1 (en) 1995-07-04
CA2071981A1 (en) 1991-06-21
AU642969B2 (en) 1993-11-04

Similar Documents

Publication Publication Date Title
OA09702A (en) The use of gaba-B selective agonists as antitussive agents.
ES8505519A1 (en) Analgesic, antagonist, and/or anorectic 14-fluoromorphinans.
ZA907597B (en) Substituted 2-amidotetralins as melatonin agonists and antagonists
BE890522A (en) PROPHYLACTIC AND THERAPEUTIC COMPOSITION FOR PROSTATE HYPERPLASIA AND ITS USE
IT1161894B (en) PROCEDURE AND EQUIPMENT FOR LIQUEFIING AN ADHESIVE INTENDED FOR USE IN THE MELTED STATE
EP0424028A3 (en) S(+)-ibuprofen-l-amino acid and s(+)-ibuprofen-d-amino acid as onset hastened enhanced analgesics
CA2002859A1 (en) Method of treating epithelial disorders
BE890521A (en) PROPHYLACTIC AND THERAPEUTIC COMPOSITION FOR PROSTATE HYPERPLASIA AND ITS USE
PH16822A (en) Method and composition for the treatment of pain
DK345889D0 (en) USE OF 5-HT-3 RECEPTOR ANTAGONIST
ES2038034T3 (en) AQUEOUS GELIFICABLE BUFFER COMPOSITION AND ITS USE FOR IMPROVED OIL RECOVERY.
SE9402880D0 (en) New peptide derivatives
MY103434A (en) Antitussive liquide compositions containing phenol
DE3370762D1 (en) Compositions for use in increasing brain tyrosine levels
PH21601A (en) Method of lowering lipid levels
EP0204954A3 (en) Use of dopamine agonists in the treatment of psychostimulant addiction
HU904426D0 (en) 8-alpha-acyl-amino-ergoline derivatives and their utilization as medicament
GB8925887D0 (en) Penetrant composition and process for use
GB2158724A (en) Material of connective elements for soft tissues and internal organs
DE69019308D1 (en) Use of an oxide superconductor.
AU5565890A (en) An acaricidal composition and use thereof in disinfesting treatments
GB8926611D0 (en) Compound and its use
BG101325A (en) Use of muramyl peptide compounds
PT801639E (en) METHOD FOR THE PREPARATION OF REPLACED ANTHRAQUINONES AND THEIR USE FOR THE PREPARATION OF QUEEN
ES2075224T3 (en) METHOD AND APPARATUS FOR PLACING AN INSERTION PIECE IN A CONTAINER.